Advertisement

Nasopharynx

  • Gregory D. Judy
  • Bhishamjit S. Chera
Chapter

Abstract

Radiation therapy is the primary treatment for nasopharyngeal carcinoma given its difficult anatomical location for surgical resection and the knowledge of it being a radiosensitive tumor that demonstrates a dose-response to radiation. Traditionally, more advanced tumors have a significant local failure rate, in part because the dose of radiation that can be delivered is limited by critical adjacent normal structures. Various methods including brachytherapy and SBRT allow for dose escalation while also minimizing dose to the surrounding normal tissue, with SBRT also providing the benefit of being noninvasive. This chapter summarizes the use of hypofractionated RT, focusing on SBRT, for nasopharyngeal carcinoma in the definitive setting where it is used as a boost to traditional EBRT, as well as in the re-irradiation setting.

Keywords

Nasopharyngeal carcinoma SBRT Hypofractionation Re-irradiation 

References

  1. 1.
    Epidemiology, etiology, and diagnosis of nasopharyngeal carcinoma. Accessed 21 July 2016.Google Scholar
  2. 2.
    Lee N, Nadeem R, Ove R, Laufer Reyngold M, Foote LR, Bonner AJ. Nasopharyngeal carcinoma. Clinical radiation oncology. Philadelphia, PA: Saunders/Elsevier; 2016. p. 629–48.CrossRefGoogle Scholar
  3. 3.
    Hara W, Loo BW Jr, Goffinet DR, et al. Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy in patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2008;71:393–400.CrossRefPubMedGoogle Scholar
  4. 4.
    Chen HH, Tsai ST, Wang MS, et al. Experience in fractionated stereotactic body radiation therapy boost for newly diagnosed nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2006;66:1408–14.CrossRefPubMedGoogle Scholar
  5. 5.
    Yamazaki H, Ogita M, Himei K, et al. Hypofractionated stereotactic radiotherapy using CyberKnife as a boost treatment for head and neck cancer, a multi-institutional survey: impact of planning target volume. Anticancer Res. 2014;34:5755–9.PubMedGoogle Scholar
  6. 6.
    Bakst RL, Lee N, Pfister DG, et al. Hypofractionated dose-painting intensity modulated radiation therapy with chemotherapy for nasopharyngeal carcinoma: a prospective trial. Int J Radiat Oncol Biol Phys. 2011;80:148–53.CrossRefPubMedGoogle Scholar
  7. 7.
    Chua DT, Wu SX, Lee V, Tsang J. Comparison of single versus fractionated dose of stereotactic radiotherapy for salvaging local failures of nasopharyngeal carcinoma: a matched-cohort analysis. Head Neck Oncol. 2009;1:13.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Seo Y, Yoo H, Yoo S, et al. Robotic system-based fractionated stereotactic radiotherapy in locally recurrent nasopharyngeal carcinoma. Radiother Oncol. 2009;93:570–4.CrossRefPubMedGoogle Scholar
  9. 9.
    Ozyigit G, Cengiz M, Yazici G, et al. A retrospective comparison of robotic stereotactic body radiotherapy and three-dimensional conformal radiotherapy for the reirradiation of locally recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2011;81:e263–8.CrossRefPubMedGoogle Scholar
  10. 10.
    Wu SX, Chua DT, Deng ML, et al. Outcome of fractionated stereotactic radiotherapy for 90 patients with locally persistent and recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2007;69:761–9.CrossRefPubMedGoogle Scholar
  11. 11.
    Benedict SH, Yenice KM, Followill D, et al. Stereotactic body radiation therapy: the report of AAPM task group 101. Med Phys. 2010;37:4078–101.CrossRefPubMedGoogle Scholar
  12. 12.
    Yau TK, Sze WM, Lee WM, et al. Effectiveness of brachytherapy and fractionated stereotactic radiotherapy boost for persistent nasopharyngeal carcinoma. Head Neck. 2004;26:1024–30.CrossRefPubMedGoogle Scholar
  13. 13.
    Pai PC, Chuang CC, Wei KC, Tsang NM, Tseng CK, Chang CN. Stereotactic radiosurgery for locally recurrent nasopharyngeal carcinoma. Head Neck. 2002;24:748–53.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Gregory D. Judy
    • 1
    • 2
  • Bhishamjit S. Chera
    • 1
    • 2
  1. 1.Department of Radiation OncologyUniversity of North Carolina School of MedicineChapel HillUSA
  2. 2.Lineberger Comprehensive Cancer CenterUniversity of North Carolina School of MedicineChapel HillUSA

Personalised recommendations